Premium Nahrungsergänzungsmittel | artgerecht

FABP4 - Fatty Acid Binding Protein 4: Function & Role

FABP4 (Fatty Acid Binding Protein 4) is an intracellular fatty acid transport protein found mainly in fat cells and macrophages, playing a key role in metabolic and cardiovascular diseases.

Regular tips about health Regular tips about health

Things worth knowing about "FABP4"

FABP4 (Fatty Acid Binding Protein 4) is an intracellular fatty acid transport protein found mainly in fat cells and macrophages, playing a key role in metabolic and cardiovascular diseases.

What is FABP4?

FABP4 (Fatty Acid Binding Protein 4), also known as the aP2 protein, is a small intracellular lipid-binding protein predominantly expressed in adipocytes (fat cells) and macrophages (immune cells). It belongs to the family of fatty acid-binding proteins (FABPs) and plays a central role in the intracellular transport and metabolism of long-chain fatty acids and retinoids.

Biological Function

FABP4 binds hydrophobic molecules such as fatty acids and shuttles them to various cellular compartments, including the nucleus, mitochondria, and endoplasmic reticulum. Through this activity, FABP4 is involved in several key biological processes:

Fatty acid metabolism: FABP4 coordinates the uptake, transport, and oxidation of fatty acids in adipocytes.
Inflammatory regulation: In macrophages, FABP4 modulates pro-inflammatory signaling pathways and influences the production of inflammatory mediators.
Insulin signaling: FABP4 interacts with the insulin signaling pathway and affects the body insulin sensitivity.
Gene expression: Through interactions with nuclear receptors such as PPARγ, FABP4 influences the transcription of genes involved in lipid and glucose metabolism.

Clinical Significance

Elevated circulating FABP4 levels in the bloodstream have been associated with various metabolic and cardiovascular diseases. FABP4 is therefore being studied as a potential biomarker for these conditions:

Obesity and Metabolic Syndrome

In overweight and obese individuals, FABP4 expression in adipose tissue is increased. High serum FABP4 levels correlate with greater waist circumference, increased insulin resistance, and an unfavorable lipid profile. FABP4 is considered a marker of the metabolic syndrome.

Type 2 Diabetes

Studies show that elevated FABP4 concentrations are associated with an increased risk of developing type 2 diabetes. FABP4 influences insulin secretion in the pancreas and insulin sensitivity in the liver and muscle tissue.

Atherosclerosis and Cardiovascular Disease

FABP4 is highly expressed in foam cells (lipid-laden macrophages) within atherosclerotic plaques and promotes plaque formation. High FABP4 levels are associated with an increased risk of heart attack, stroke, and other cardiovascular events.

Non-Alcoholic Fatty Liver Disease (NAFLD)

Elevated FABP4 levels are also observed in patients with non-alcoholic fatty liver disease and may indicate more advanced hepatic steatosis.

FABP4 as a Biomarker and Therapeutic Target

Due to its close association with metabolic disorders, FABP4 is being intensively investigated as a diagnostic biomarker. A simple blood test measuring serum FABP4 levels could in the future help identify at-risk patients at an early stage.

In addition, FABP4 is being explored as a therapeutic target. Experimental FABP4 inhibitors have shown promising results in preclinical studies, improving insulin sensitivity, reducing inflammatory responses, and attenuating the development of atherosclerosis. However, clinical trials in humans are still ongoing.

Measurement of FABP4

FABP4 can be measured in blood serum using an ELISA assay (Enzyme-Linked Immunosorbent Assay). Reference values may vary depending on the laboratory, age, and sex. In general, higher FABP4 levels are considered indicative of increased metabolic and cardiovascular risk.

References

Hotamisligil, G. S. & Bernlohr, D. A. (2015): Metabolic functions of FABPs -- mechanisms and therapeutic implications. Nature Reviews Molecular Cell Biology, 16(8), 543-556. https://doi.org/10.1038/nrm4030
Xu, A. et al. (2006): The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases through activation of peroxisome proliferator-activated receptor-alpha. Journal of Clinical Investigation, 116(6), 1501-1509.
Tuncman, G. et al. (2006): A genetic variant at the fatty acid-binding protein aP2 locus reduces the risk for hypertriglyceridemia, type 2 diabetes, and cardiovascular disease. PNAS, 103(18), 6970-6975. https://doi.org/10.1073/pnas.0602178103

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.